We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$4.42B
AUM Growth
+$200M
(+4.7%)
Cap. Flow
+$138M
Cap. Flow
% of AUM
3.13%
Top 10 Holdings %
Top 10 Hldgs %
20.05%
Holding
1,701
New
123
Increased
762
Reduced
644
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
+$34.6M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$24.7M |
| 3 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$22.5M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$15.7M |
| 5 |
SPDR Gold Trust
GLD
|
+$14.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$20.4M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$15.2M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$10.9M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$10.6M |
| 5 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.64% |
| 2 | Technology | 4.52% |
| 3 | Healthcare | 4.42% |
| 4 | Consumer Staples | 4.24% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
201
DELISTED
Walgreens Boots Alliance
WBA
| $4.11M | 0.09% |
48,826
+5,337
| +12% | +$426K |
|
202
Church & Dwight Co
CHD
$24.5B
| $4.11M | 0.09% |
89,214
+6,708
| +8% | +$293K |
|
|
VBIV
203
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $4.1M | 0.09% |
58,099
+10,329
| +22% | +$683K |
|
204
Blackrock
BLK
$175B
| $4.08M | 0.09% |
11,995
-496
| -4% | -$157K |
|
205
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $4.07M | 0.09% |
77,182
-57,180
| -43% | -$3M |
|
206
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.7B
| $3.98M | 0.09% |
74,988
-25,412
| -25% | -$1.29M |
|
|
AGN
207
DELISTED
Allergan plc
AGN
| $3.98M | 0.09% |
14,847
+3,038
| +26% | +$870K |
|
208
US Bancorp
USB
$100B
| $3.97M | 0.09% |
97,781
+1,482
| +2% | +$59.1K |
|
209
Kroger
KR
$34.6B
| $3.96M | 0.09% |
103,406
-1,997
| -2% | -$77.1K |
|
210
GSK
GSK
$104B
| $3.95M | 0.09% |
77,882
-2,447
| -3% | -$122K |
|
211
First Trust Preferred Securities and Income ETF
FPE
$6.34B
| $3.94M | 0.09% |
211,208
+59,607
| +39% | +$1.11M |
|
212
iShares Biotechnology ETF
IBB
$9.82B
| $3.84M | 0.09% |
44,193
+5,100
| +13% | +$456K |
|
213
iShares Russell 2000 Growth ETF
IWO
$14.9B
| $3.84M | 0.09% |
28,948
-1,254
| -4% | -$156K |
|
214
Mondelez International
MDLZ
$78.5B
| $3.83M | 0.09% |
95,499
+3,704
| +4% | +$151K |
|
215
Clorox
CLX
$13B
| $3.82M | 0.09% |
30,334
+1,325
| +5% | +$168K |
|
216
iShares US Real Estate ETF
IYR
$4.52B
| $3.82M | 0.09% |
49,071
-39,598
| -45% | -$2.87M |
|
|
DD
217
DELISTED
Du Pont De Nemours E I
DD
| $3.81M | 0.09% |
60,227
-1,956
| -3% | -$117K |
|
218
First Trust Health Care AlphaDEX Fund
FXH
$1.12B
| $3.81M | 0.09% |
68,285
-13,724
| -17% | -$742K |
|
|
RPAI
219
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $3.76M | 0.08% |
237,080
-55,041
| -19% | -$830K |
|
220
First Trust US Equity Opportunities ETF
FPX
$1.48B
| $3.72M | 0.08% |
74,285
-23,784
| -24% | -$1.12M |
|
|
CELG
221
DELISTED
Celgene Corp
CELG
| $3.69M | 0.08% |
36,840
-6,232
| -14% | -$642K |
|
222
Union Pacific
UNP
$174B
| $3.65M | 0.08% |
45,919
-558
| -1% | -$43.1K |
|
223
Comcast
CMCSA
$89.4B
| $3.63M | 0.08% |
118,784
+4,170
| +4% | +$120K |
|
224
WisdomTree International MidCap Dividend Fund
DIM
$168M
| $3.59M | 0.08% |
64,238
-858
| -1% | -$45K |
|
225
Prospect Capital
PSEC
$1.15B
| $3.58M | 0.08% |
493,136
-18,190
| -4% | -$121K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Cambridge Investment Research Advisors held 1,701 positions worth $4.42B, up 4.7% from $4.22B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors deployed $138M of net new capital in Q1 2016, opening 123 new positions and adding to 762 existing holdings. Its largest new stake was Vanguard Long-Term Treasury ETF: 35,170 shares worth $2.83M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $20.4M trimmed.
- Cambridge Investment Research Advisors's largest Q1 2016 buy was Vanguard Long-Term Treasury ETF: 35,170 shares worth $2.83M.
- Cambridge Investment Research Advisors added most to DIPLOMAT PHARMACY, INC. in Q1 2016, an estimated $34.6M increase.
- Cambridge Investment Research Advisors's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $20.4M.
- Cambridge Investment Research Advisors fully exited iShares Currency Hedged MSCI Emerging Markets in Q1 2016, selling an estimated $1.72M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $4.42B portfolio in Q1 2016.
- Cambridge Investment Research Advisors opened 123 new positions and closed 96 in Q1 2016.
- Cambridge Investment Research Advisors's portfolio value rose 4.7% quarter-over-quarter to $4.42B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2016, filed 3 May 2016.